Peroxisome proliferators compete and ameliorate Hcy-mediated endocardial endothelial cell activation (Q44133768)

30 November 2017

Peroxisome proliferators compete and ameliorate Hcy-mediated endocardial endothelial cell activation (English)

1 reference

30 November 2017

0 references

Matthew J Hunt

1

1 reference

PubMed ID

12225971

30 November 2017

Suresh C Tyagi

series ordinal

2

1 reference

30 November 2017

1 October 2002

1 reference

American Journal of Physiology - Cell Physiology

30 November 2017

1 reference

30 November 2017

283

1 reference

30 November 2017

4

1 reference

30 November 2017

C1073-9

1 reference

Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth

30 November 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

Arterial endothelial barrier dysfunction: actions of homocysteine and the hypoxanthine-xanthine oxidase free radical generating system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

Fenofibrate raises plasma homocysteine levels in the fasted and fed states

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

Comparative toxicity and safety profile of fenofibrate and other fibric acid derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

Inhibitors of poly (ADP-ribose) synthetase protect rat cardiomyocytes against oxidant stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

Reactive oxygen species from NAD(P)H:quinone oxidoreductase constitutively activate NF-kappaB in malignant melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

The PPARalpha-leukotriene B4 pathway to inflammation control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

Hyperhomocysteinemia impairs angiogenesis in response to hindlimb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

Antihypertensive mechanisms of lipid-lowering drugs: decoding the Rosetta stone's inscriptions'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

Tissue plasminogen activator binding to the annexin II tail domain. Direct modulation by homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+,Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

Bezafibrate has an antioxidant effect: peroxisome proliferator-activated receptor alpha is associated with Cu2+, Zn2+-superoxide dismutase in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

Mycoplasmas induce collagenase in BALB/c 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

Correlation between plasma homocyst(e)ine and aortic atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

Endothelial activation and development of coronary artery disease in transplanted human hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

Reversal of endocardial endothelial dysfunction by folic acid in homocysteinemic hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

Induction of oxidative stress by homocyst(e)ine impairs endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

Comparative genomics and host resistance against infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

Hypercoagulable thrombophilic defects and hyperhomocysteinemia in patients with recurrent pregnancy loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

Decreased rate of coronary restenosis after lowering of plasma homocysteine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

High homocysteine levels are independently related to isolated systolic hypertension in older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

A modified Bonferroni method for discrete data

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

Differential regulation of extracellular matrix metalloproteinase and tissue inhibitor by heparin and cholesterol in fibroblast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

Inhibitors directed to binding domains in neutrophil elastase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

Dysfunction of nitric oxide mediation in isolated rat arterioles with methionine diet-induced hyperhomocysteinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

Differential activation of peroxisome proliferator-activated receptors by eicosanoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00152.2002

10.1152/AJPCELL.00152.2002

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference

PubMed ID

12225971